These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27838315)

  • 1. Neuropsychiatric Predictors of Cognitive Decline in Parkinson Disease: A Longitudinal Study.
    Pirogovsky-Turk E; Moore RC; Filoteo JV; Litvan I; Song DD; Lessig SL; Schiehser DM
    Am J Geriatr Psychiatry; 2017 Mar; 25(3):279-289. PubMed ID: 27838315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms.
    Meng D; Jin Z; Wang Y; Fang B
    CNS Neurosci Ther; 2023 Aug; 29(8):2259-2266. PubMed ID: 36924300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.
    Jones JD; Kurniadi NE; Kuhn TP; Szymkowicz SM; Bunch J; Rahmani E
    Neuropsychology; 2019 Nov; 33(8):1111-1120. PubMed ID: 31343240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson disease.
    Park JH; Lee SH; Kim Y; Park SW; Byeon GH; Jang JW;
    Psychogeriatrics; 2020 Nov; 20(6):880-890. PubMed ID: 32840032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential contributions of depression, apathy, and anxiety to neuropsychological performance in Parkinson's disease versus essential tremor.
    Ratajska AM; Scott BM; Lopez FV; Kenney LE; Foote KD; Okun MS; Price C; Bowers D
    J Clin Exp Neuropsychol; 2022 Nov; 44(9):651-664. PubMed ID: 36600515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
    Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
    JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of depression in mild Parkinson's disease on longitudinal motor and cognitive function.
    Ng A; Chander RJ; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1056-60. PubMed ID: 26117438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caregiver report of apathy predicts dementia in Parkinson's disease.
    Fitts W; Weintraub D; Massimo L; Chahine L; Chen-Plotkin A; Duda JE; Hurtig HI; Rick J; Trojanowski JQ; Dahodwala N
    Parkinsonism Relat Disord; 2015 Aug; 21(8):992-5. PubMed ID: 26117435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients.
    Siciliano M; Trojano L; De Micco R; De Mase A; Garramone F; Russo A; Tedeschi G; Tessitore A
    Parkinsonism Relat Disord; 2017 Dec; 45():63-68. PubMed ID: 29037500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis.
    Martin GP; McDonald KR; Allsop D; Diggle PJ; Leroi I
    J Neurol; 2020 Jan; 267(1):214-227. PubMed ID: 31616991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease.
    Le Heron C; Horne KL; MacAskill MR; Livingstone L; Melzer TR; Myall D; Pitcher T; Dalrymple-Alford J; Anderson T; Harrison S
    Neurology; 2024 Jun; 102(12):e209301. PubMed ID: 38830182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Step length predicts executive dysfunction in Parkinson's disease: a 3-year prospective study.
    Amboni M; Iuppariello L; Iavarone A; Fasano A; Palladino R; Rucco R; Picillo M; Lista I; Varriale P; Vitale C; Cesarelli M; Sorrentino G; Barone P
    J Neurol; 2018 Oct; 265(10):2211-2220. PubMed ID: 30014240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and demographic correlates of apathy in Parkinson's disease.
    Brown DS; Barrett MJ; Flanigan JL; Sperling SA
    J Neurol; 2019 Feb; 266(2):507-514. PubMed ID: 30604055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State anxiety predicts cognitive performance in patients with Parkinson's disease.
    Ehgoetz Martens KA; Silveira CRA; Intzandt BN; Almeida QJ
    Neuropsychology; 2018 Nov; 32(8):950-957. PubMed ID: 30284873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apathy in Mild Parkinson's Disease: Neuropsychological and Neuroimaging Evidence.
    Alzahrani H; Antonini A; Venneri A
    J Parkinsons Dis; 2016 Oct; 6(4):821-832. PubMed ID: 27567885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.